Genomic Profiling of Breast Cancer: A Multidisciplinary approach in early stage breast cancer treatment decisions - European Medical Journal

Continue

Genomic Profiling of Breast Cancer: A Multidisciplinary approach in early stage breast cancer treatment decisions

Oncology

Join Agendia for a Multidisciplinary Discussion on the Increasing Role of Genomic Profiling in Early Stage Breast Cancer

  • Understand the latest data supporting the utility of Agendia’s assays: MammaPrint® andBluePrint® for early-stage breast cancer patients
  • Review and appreciate the real-world impact of MammaPrint and BluePrint
  • Recommend genomic profiling for pre-and post-operative breast cancer treatment planning

This virtual webinar presentation featuring Dr. Cathy Graham & Dr. William Audeh was broadcast on 21st June 2022.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

We’ve noticed you’re accessing
from North/South America.